Viraday-tablets

Q1: What is Viraday (EFV/FTC/TDF or EFV/3TC/TDF) used for?

Viraday is a triple fixed-dose combination of Tenofovir + Lamivudine (or Emtricitabine) + Efavirenz in a single tablet taken once daily. It was previously one of the most widely prescribed first-line HIV regimens globally, still used extensively in resource-limited settings.

Q2: How does Efavirenz as the NNRTI component work?

Efavirenz is an NNRTI that binds directly to HIV reverse transcriptase at an allosteric site, locking the enzyme in an inactive conformation. This blocks RNA-to-DNA copying by a different mechanism than NRTIs, providing synergistic suppression with the NRTI backbone.

Q3: Why should Viraday be taken in the evening on an empty stomach?

Efavirenz causes CNS side effects (dizziness, vivid dreams, difficulty concentrating) in 50%+ of patients. Evening dosing allows these to occur during sleep, minimizing daytime impact. High-fat meals increase Efavirenz absorption by 2x, worsening CNS effects — avoid fatty meals close to dosing.

Q4: How long do Efavirenz CNS side effects last?

Dizziness, vivid dreams, and difficulty concentrating typically begin in the first 1–2 weeks and resolve in most patients within 4–6 weeks as the body adapts. If severe psychiatric symptoms (depression, suicidal thoughts, psychosis) occur, medical evaluation is required.

Q5: What is the HBV coverage from the NRTI backbone?

The Tenofovir and Lamivudine/Emtricitabine components provide dual HBV coverage in co-infected patients. Never stop this regimen in HIV/HBV patients without maintaining HBV-active therapy to prevent potentially severe hepatitis flares.

Q6: What are the most common side effects?

CNS effects (dizziness, vivid dreams, insomnia), rash, nausea, and diarrhea are most common. Rash occurs in ~5–10% during the first 2 weeks — benign in most cases, but any spreading or blistering rash requires immediate evaluation.

Q7: What serious side effects require emergency care?

Seek immediate care for: Stevens-Johnson syndrome (severe blistering rash), severe psychiatric symptoms (suicidal ideation, psychosis, severe depression), severe hepatotoxicity (jaundice, dark urine), or lactic acidosis from the NRTI backbone.

Q8: What drug interactions must I know about?

Efavirenz is a CYP3A4 inducer — it reduces levels of many drugs including some contraceptives, statins, and other antiretrovirals. TDF interactions include didanosine (contraindicated). A comprehensive drug interaction check is essential.

Q9: Is Viraday safe during pregnancy?

Efavirenz was previously contraindicated in the first trimester due to animal data suggesting neural tube defects. Current data in humans have not confirmed this risk, and many guidelines now allow use throughout pregnancy. Discuss with your HIV/OB specialist.

Q10: What monitoring is needed on Viraday therapy?

CD4 count and viral load at baseline and every 3–6 months. Renal function (TDF component). Liver function tests. CNS symptom assessment especially in the first 6 weeks. Consider lipid screening with long-term Efavirenz use.

Q11: How should Viraday be stored?

Store at room temperature away from light and moisture. Keep in original packaging out of reach of children.

Q12: Do I need a prescription?

Yes. Viraday requires specialist HIV prescribing with baseline CD4 count, viral load, and renal function assessment, plus counselling on CNS side effects.